ORAL PRESENTATIONS: Friday, 12 April 2019
Hepatitis B – drug development
PS-080-Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg < 100 IU/ml threshold

https://doi.org/10.1016/S0618-8278(19)30092-1Get rights and content

References (0)

Cited by (0)

View full text